(Q28365213)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11353643%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin B (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11353643%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

0 references

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11353643%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Moore CB

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11353643%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Walls CM

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11353643%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 June 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11353643%20AND%20SRC:MED&resulttype=core&format=json

Antimicrobial Agents and Chemotherapy

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11353643%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11353643%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11353643%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

1882-1885

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11353643%20AND%20SRC:MED&resulttype=core&format=json

In vitro activities of terbinafine against cutaneous isolates of Candida albicans and other pathogenic yeasts

7 November 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90563

Aspergillus fumigatus and aspergillosis

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90563

An evaluation of the in vitro activity of terbinafine

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90563

In vitro comparison of terbinafine and itraconazole against Penicillium marneffei

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90563

In vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90563

Invasive aspergillosis caused by Aspergillus ustus: case report and review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90563

A four-year review of fatal Aspergillosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90563

Multiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolites

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90563

MIC and fungicidal activity of terbinafine against clinical isolates of Aspergillus spp.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90563

Aspergillus versicolor as cause of onychomycosis: report of 12 cases and susceptibility testing to antifungal drugs.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90563

Activity of terbinafine against Pneumocystis carinii in vitro and its efficacy in the treatment of experimental pneumonia

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90563

Lack of correlation of in vitro amphotericin B susceptibility testing with outcome in a murine model of Aspergillus infection.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90563

In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans

27 November 2018

1 reference

12 December 2020

Refractory pulmonary aspergillosis: compassionate trial with terbinafine

1 reference

12 December 2020

Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection

1 reference

12 December 2020

Invasive aspergillosis

1 reference

12 December 2020

10.1128/AAC.45.6.1882-1885.2001

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11353643%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11353643%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

PubMed publication ID

11353643

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11353643%20AND%20SRC:MED&resulttype=core&format=json